These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 6295266

  • 1. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [Abstract] [Full Text] [Related]

  • 2. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG, McGlohn MS.
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.
    Corrado ML, Kramer M, Cummings M, Eng RH.
    Sabouraudia; 1982 Jun; 20(2):109-13. PubMed ID: 6287653
    [Abstract] [Full Text] [Related]

  • 4. Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.
    Eng RH, Person A, Mangura C, Chmel H, Corrado M.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):688-90. PubMed ID: 6275783
    [Abstract] [Full Text] [Related]

  • 5. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD, Gudmundsson S, Vogelman B, Craig WA.
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [Abstract] [Full Text] [Related]

  • 6. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
    Mary C, Goudard M, Blancard A, Quilici M, Regli P.
    Ann Biol Clin (Paris); 1989 Jul; 47(9):546-9. PubMed ID: 2558599
    [Abstract] [Full Text] [Related]

  • 7. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F, Raab W.
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract] [Full Text] [Related]

  • 8. Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
    Beggs WH, Sarosi GA.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):355-7. PubMed ID: 6280603
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM, Llosá J, Martinez Brocal A, Ventosa A.
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [Abstract] [Full Text] [Related]

  • 10. Determination of antifungal activity of polyenzyme preparation Candidaseb using in vitro methods.
    Joshi A, Deshpande S, Dohe V, Risbud S, Bharadwaj R.
    Hindustan Antibiot Bull; 1992 Apr; 49-50(1-4):10-3. PubMed ID: 19957538
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species.
    Yangco BG, Okafor JI, TeStrake D.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):413-6. PubMed ID: 6329078
    [Abstract] [Full Text] [Related]

  • 12. The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.
    Siau H, Kerridge D.
    J Antimicrob Chemother; 1998 Mar; 41(3):357-66. PubMed ID: 9578162
    [Abstract] [Full Text] [Related]

  • 13. Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
    Perfect JR, Durack DT.
    J Infect Dis; 1982 Sep; 146(3):429-35. PubMed ID: 6286799
    [Abstract] [Full Text] [Related]

  • 14. [In vitro susceptibility of Cryptococcus strains to 5 antifungal drugs].
    Bava AJ, Negroni R.
    Rev Inst Med Trop Sao Paulo; 1989 Sep; 31(5):346-50. PubMed ID: 2560840
    [Abstract] [Full Text] [Related]

  • 15. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Doern GV, Tubert TA, Chapin K, Rinaldi MG.
    J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
    [Abstract] [Full Text] [Related]

  • 16. Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
    Fromtling RA, Abruzzo GK, Bulmer GS.
    Mycopathologia; 1986 Apr; 94(1):27-30. PubMed ID: 3014339
    [Abstract] [Full Text] [Related]

  • 17. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.
    Moody MR, Young VM, Morris MJ, Schimpff SC.
    Antimicrob Agents Chemother; 1980 May; 17(5):871-5. PubMed ID: 6249197
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL, Monroy E, Negrete E, Vaca S.
    Rev Latinoam Microbiol; 2002 May; 44(2):65-8. PubMed ID: 17063773
    [Abstract] [Full Text] [Related]

  • 19. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
    Gehrt A, Peter J, Pizzo PA, Walsh TJ.
    J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745
    [Abstract] [Full Text] [Related]

  • 20. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S, Wagner G, Espinel-Ingroff E, Davis BA.
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.